Bayer Announces the Launch of Aleve® Direct Therapy™

On Jul 15, 2016

Bayer, in Whippany, announced that Aleve® Direct Therapy™, a safe, drug-free, pain relief device, is now available at retailers nationwide in the analgesics aisle. Aleve Direct Therapy uses the same TENS (Transcutaneous Electrical Nerve Stimulation) technology used by doctors to provide consumers with deep penetrating relief at the source of lower back pain. TENS is a non-invasive, drug-free method of controlling pain that works by delivering stimulating pulses at the site of pain.

“For people suffering from lower back pain, the availability of the Aleve Direct Therapy TENS Device is good news. The device provides drug-free, deep penetrating lower-back pain relief, without a prescription,” said Fred Duchin, Vice President of Marketing Analgesics of Cough & Cold, Cardiovascular, Consumer Health Division.

Aleve Direct Therapy is indicated for the temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities. Aleve Direct Therapy is regulated as a Class II medical device and was cleared by the U.S. Food and Drug Administration. Its unique patented waveform technology can provide deep penetrating relief by blocking the body’s pain signals and by releasing endorphins in the areas of pain – the two theories behind how TENS technology works.

“Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to visit the doctor. It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs,” said Andre Schmidt, Vice President, US Medical Affairs, Consumer Health Division. “We are pleased to be able to provide this safe, drug-free and convenient self-care option to help consumers get the relief they need from lower back pain.”

Related Articles: